CYTOKINES AND GROWTH-FACTORS IN ENDOTHELIAL DYSFUNCTION

被引:57
|
作者
LEFER, AM
MA, XL
机构
关键词
ISCHEMIA; MYOCARDIAL; CYTOKINES; TRANSFORMING GROWTH FACTOR-BETA; NEUTROPHILS; MYOCARDIAL DEPRESSANT FACTOR; ENDOTHELIUM; ENDOTHELIUM-DERIVED RELAXING FACTOR; SPLANCHNIC CIRCULATION; TUMOR NECROSIS FACTOR; SUPEROXIDE DISMUTASE; CRITICAL ILLNESS;
D O I
10.1097/00003246-199302001-00003
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: The purpose of this focused review is to call attention to the important interrelationships between growth factors (e.g., transforming growth factor-beta) and cytokines (e.g., tumor necrosis factor [TNF]) on endothelial function as characterized by the ability of the endothelium to release endothelium-derived relaxing factor. Background and Methods: Myocardial ischemia followed by reperfusion leads to a severe degree of endothelial dysfunction characterized by an impaired vasodilator response to endothelial-dependent vasodilators. The reduction in endothelial-dependent responses occurs rapidly after the onset of reperfusion. Endothelial dysfunction was studied in coronary artery as well as superior mesenteric artery rings, and the effects of cytokines, transforming growth factor-beta, and free radicals were assessed. Results: Oxygen-derived free radicals (i.e., superoxide anion) and cytokines (i.e., TNF) contribute to this endothelial dysfunction, which is characterized by a loss of endothelium-derived relaxing factor, now known to be identical to nitric oxide. Agents such as superoxide dismutase or transforming growth factor-beta can significantly preserve endothelial integrity during ischemia-reperfusion states. Conclusions: Endothelial dysfunction is an early and critical phenomenon occurring in ischemia-reperfusion injury both in the coronary and the mesenteric circulations.
引用
收藏
页码:S9 / S14
页数:6
相关论文
共 50 条
  • [1] CYTOKINES AND GROWTH-FACTORS IN IMPLANTATION
    HAIMOVICI, F
    ANDERSON, DJ
    MICROSCOPY RESEARCH AND TECHNIQUE, 1993, 25 (03) : 201 - 207
  • [2] CYTOKINES AND GROWTH-FACTORS IN ATHEROGENESIS
    CLINTON, SK
    LIBBY, P
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1992, 116 (12) : 1292 - 1300
  • [3] CYTOKINES, GROWTH-FACTORS AND INFLAMMATION
    PUJOL, JP
    REVUE DU RHUMATISME, 1988, 55 (06): : 430 - 434
  • [4] CYTOKINES AND GROWTH-FACTORS - FOREWORD
    BRENNER, MK
    BAILLIERES CLINICAL HAEMATOLOGY, 1994, 7 (01): : R9 - R10
  • [5] THE REGULATION OF HUMAN ENDOTHELIAL-CELL GROWTH, DIFFERENTIATION AND SENESCENCE BY GROWTH-FACTORS AND CYTOKINES
    MACIAG, T
    HOLLAND, JH
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (02) : 190 - 190
  • [6] HYBRID CYTOKINES AS HEMATOPOIETIC GROWTH-FACTORS
    WILLIAMS, DE
    PARK, LS
    BROXMEYER, HE
    LU, L
    INTERNATIONAL JOURNAL OF CELL CLONING, 1991, 9 (06): : 542 - 547
  • [7] CYTOKINES AND GROWTH-FACTORS IN RENAL INJURY
    SEDOR, JR
    SEMINARS IN NEPHROLOGY, 1992, 12 (05) : 428 - 440
  • [8] CYTOKINES AS AUTOCRINE GROWTH-FACTORS IN MALIGNANCIES
    KAWANO, M
    KURAMOTO, A
    HIRANO, T
    KISHIMOTO, T
    CANCER SURVEYS, 1989, 8 (04) : 905 - 919
  • [9] GROWTH-FACTORS, CYTOKINES, AND VASCULAR INJURY
    FAGIN, JA
    FORRESTER, JS
    TRENDS IN CARDIOVASCULAR MEDICINE, 1992, 2 (03) : 90 - 94
  • [10] GROWTH-FACTORS IN ENDOTHELIAL REGENERATION
    BRINDLE, NPJ
    CARDIOVASCULAR RESEARCH, 1993, 27 (07) : 1162 - 1172